Bar-Eli M - Search Results

1

Antibodies to two defined regions of the transforming protein pp60src interact specifically with the epidermal growth factor receptor kinase system.

Lax I, Bar-Eli M, Yarden Y, Libermann TA, Schlessinger J. Lax I, et al. Proc Natl Acad Sci U S A. 1984 Oct;81(19):5911-5. doi: 10.1073/pnas.81.19.5911. Proc Natl Acad Sci U S A. 1984. PMID: 6207534 Free PMC article.

2

Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors.

Kuwai T, Nakamura T, Sasaki T, Kim SJ, Fan D, Villares GJ, Zigler M, Wang H, Bar-Eli M, Kerbel RS, Fidler IJ. Kuwai T, et al. Neoplasia. 2008 May;10(5):489-500. doi: 10.1593/neo.08200. Neoplasia. 2008. PMID: 18472966 Free PMC article.

3

Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.

Ahuja H, Bar-Eli M, Advani SH, Benchimol S, Cline MJ. Ahuja H, et al. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6783-7. doi: 10.1073/pnas.86.17.6783. Proc Natl Acad Sci U S A. 1989. PMID: 2771957 Free PMC article.

4

Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels.

Lin Q, Balasubramanian K, Fan D, Kim SJ, Guo L, Wang H, Bar-Eli M, Aldape KD, Fidler IJ. Lin Q, et al. Neoplasia. 2010 Sep;12(9):748-54. doi: 10.1593/neo.10602. Neoplasia. 2010. PMID: 20824051 Free PMC article.

5

Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.

McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, Fidler IJ, Bar-Eli M. McGary EC, et al. Clin Cancer Res. 2002 Nov;8(11):3584-91. Clin Cancer Res. 2002. PMID: 12429650

6

Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.

Blehm KN, Spiess PE, Bondaruk JE, Dujka ME, Villares GJ, Zhao YJ, Bogler O, Aldape KD, Grossman HB, Adam L, McConkey DJ, Czerniak BA, Dinney CP, Bar-Eli M. Blehm KN, et al. Clin Cancer Res. 2006 Aug 1;12(15):4671-7. doi: 10.1158/1078-0432.CCR-06-0407. Clin Cancer Res. 2006. PMID: 16899617

7

Targeting EGFR in bladder cancer.

Villares GJ, Zigler M, Blehm K, Bogdan C, McConkey D, Colin D, Bar-Eli M. Villares GJ, et al. World J Urol. 2007 Dec;25(6):573-9. doi: 10.1007/s00345-007-0202-7. Epub 2007 Aug 10. World J Urol. 2007. Retraction in: World J Urol. 2012 Oct;30(5):723. doi: 10.1007/s00345-012-0940-z. PMID: 17690890 Retracted.

8

Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape.

Zigler M, Villares GJ, Lev DC, Melnikova VO, Bar-Eli M. Zigler M, et al. Am J Clin Dermatol. 2008;9(5):307-11. doi: 10.2165/00128071-200809050-00004. Am J Clin Dermatol. 2008. PMID: 18717605 Review.

9

Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.

Villares GJ, Zigler M, Wang H, Melnikova VO, Wu H, Friedman R, Leslie MC, Vivas-Mejia PE, Lopez-Berestein G, Sood AK, Bar-Eli M. Villares GJ, et al. Cancer Res. 2008 Nov 1;68(21):9078-86. doi: 10.1158/0008-5472.CAN-08-2397. Cancer Res. 2008. PMID: 18974154 Free PMC article.

10

Emerging roles of PAR-1 and PAFR in melanoma metastasis.

Melnikova VO, Villares GJ, Bar-Eli M. Melnikova VO, et al. Cancer Microenviron. 2008 Dec;1(1):103-11. doi: 10.1007/s12307-008-0002-7. Epub 2008 Feb 20. Cancer Microenviron. 2008. PMID: 19308689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters